Billing and Coding: MolDX: Cystatin C Measurement - R1

This coverage article has been revised and published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: October 1, 2020
Summary of Article Changes:
Under ICD-10 Codes that Support Medical Necessity - Group 1: Codes - added codes:
N18.30: Chronic kidney disease, stage 3 unspecified
N18.31: Chronic kidney disease, stage 3a
N18.32  Chronic kidney disease, stage 3b

Under ICD-10 Codes that Support Medical Necessity - Group 1: Codes - deleted codes:
N18.3: Chronic kidney disease, stage 3 (moderate)

This revision is due to the annual ICD-10 Code update and is effective on October 1, 2020.

Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.

To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.

 

            Last Updated Mon, 28 Sep 2020 14:56:29 +0000